Both of these disorders need continuous medical intervention, and GLP-1 agonists are gaining prominence as an ideal therapy owing to their ability to provide both diabetes and obesity control at once
April 1, 2024: Novo Nordisk Says Some Products for Sale Arent Really Wegovy, Files Lawsuit Pharma giant Novo Nordisk continues to file lawsuits against pharmacies that sell compounded semaglutide, the active ingredient in Wegovy
As demand for GLP-1 medications has increased, a growing number of companies have begun offering so-called compounded GLP-1 products
Eslami combines surgical expertise with an artistic eye to help patients achieve natural, confidence-building results tailored to their goals
Visit our specials page for details on our current limited-time discounts on our wellness and rejuvenation services
Risks During General Anesthesia and Deep Sedation GLP-1 agonists are associated with adverse GI effects such as nausea, vomiting, and delayed gastric emptying